- Home
- YJ vs BCLI Comparison
YJ vs BCLI Comparison
Compare YJ & BCLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YJ
- BCLI
- Stock Information
- Founded
- YJ 2015
- BCLI 2000
- Country
- YJ China
- BCLI United States
- Employees
- YJ N/A
- BCLI N/A
- Industry
- YJ Other Specialty Stores
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- YJ Consumer Discretionary
- BCLI Health Care
- Exchange
- YJ Nasdaq
- BCLI Nasdaq
- Market Cap
- YJ 8.8M
- BCLI 9.9M
- IPO Year
- YJ 2019
- BCLI N/A
- Fundamental
- Price
- YJ $1.78
- BCLI $1.19
- Analyst Decision
- YJ
- BCLI Strong Buy
- Analyst Count
- YJ 0
- BCLI 1
- Target Price
- YJ N/A
- BCLI $30.00
- AVG Volume (30 Days)
- YJ 7.0K
- BCLI 35.3K
- Earning Date
- YJ 04-11-2025
- BCLI 03-31-2025
- Dividend Yield
- YJ N/A
- BCLI N/A
- EPS Growth
- YJ N/A
- BCLI N/A
- EPS
- YJ N/A
- BCLI N/A
- Revenue
- YJ $66,957,730.00
- BCLI N/A
- Revenue This Year
- YJ N/A
- BCLI $170.09
- Revenue Next Year
- YJ N/A
- BCLI N/A
- P/E Ratio
- YJ N/A
- BCLI N/A
- Revenue Growth
- YJ N/A
- BCLI N/A
- 52 Week Low
- YJ $1.42
- BCLI $1.05
- 52 Week High
- YJ $3.56
- BCLI $11.25
- Technical
- Relative Strength Index (RSI)
- YJ 51.28
- BCLI 29.41
- Support Level
- YJ $1.70
- BCLI $1.15
- Resistance Level
- YJ $1.85
- BCLI $1.28
- Average True Range (ATR)
- YJ 0.08
- BCLI 0.12
- MACD
- YJ -0.02
- BCLI -0.02
- Stochastic Oscillator
- YJ 48.63
- BCLI 11.54
About YJ Yunji Inc. American Depository Shares
Yunji Inc is a social e-commerce platform in China that offers a membership-based model that leverages the power of social interaction. The company provides a host of selected commodities such as beauty and personal care, mobile phones and digital products, baby and maternal products, toys, fruits, and other fresh products. It has expanded to operate its business, including the marketplace, on a diverse range of sales channels and other platforms. Geographically, the firm operates in China.
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.